Harnessing the potential of genetics and epigenetics for new therapeutics and diagnostics

 

January 7, 2017 

Montreal EpiTerapiahas signed an exclusive distribution agreement with DHEA Horizon for "DHEA addiction treatment program" in Canada, India, Russia, Kazakhstan and Georgia.